Table 2.
Change from the baseline (week 0) of study outcomes, with repeated measures within-group p-values.
| Placebo (n = 18) | Active (n = 21) | |||||
|---|---|---|---|---|---|---|
| Mean | SEM | p-Value | Mean | SEM | p-Value | |
| TC (mg/dL), week 6 | −13.4 | 6.4 | 0.766 | −20.9 | 5.7 | 0.007 |
| TC (mg/dL), week 12 | −2.8 | 9.4 | −18.0 | 6.0 | ||
| LDL-C (mg/dL), week 6 | −17.1 | 5.8 | 0.571 | −16.0 | 5.0 | 0.008 |
| LDL-C (mg/dL), week 12 | −3.6 | 6.2 | −15.3 | 5.2 | ||
| HDL-C (mg/dL), week 6 | −1.2 | 1.3 | 0.847 | 0.1 | 1.4 | 0.004 |
| HDL-C (mg/dL), week 12 | 0.4 | 2.0 | 3.1 | 1.0 | ||
| TG (mg/dL), week 6 | 3.3 | 10.1 | 0.370 | −32.4 | 15.1 | 0.015 |
| TG (mg/dL), week 12 | 10.7 | 11.6 | −30.3 | 11.4 | ||
| Body weight (kg), week 12 | −0.4 | 0.4 | 0.249 | −1.4 | 0.4 | <0.001 |
| BMI (kg/m2), week 12 | −0.2 | 0.1 | 0.215 | −0.5 | 0.1 | 0.001 |
| Body Fat (%), week 12 | −0.8 | 0.4 | 0.061 | −1.3 | 0.4 | 0.003 |
Statistically significant p-Values are indicated in bold. Abbreviations: SEM: Standard Error of the Mean; TC: Total Cholesterol; LDL-C: Low-Density Lipoprotein Cholesterol; HDL-C: High-Density Lipoprotein Cholesterol; TG: Triglycerides; BMI: Body Mass Index.